Silver Book Fact

“Sherri Selph was 41 when she was first diagnosed with second-stage congestive heart failure. However, her rapidly diminishing health led to a diagnosis of end-stage heart disease. A heart transplant was not an option. Survival statistics for patients with Sherrie’s condition are grim. Even with the best treatment available, only 50 percent of heart failure patients live beyond a year.
Her doctor suggested that Sherri enroll in a clinical trial. Sherri soon became a patient and a member of the group that received an implantable heart pump.
The results were immediate. Four days after receiving her heart pump Sherri was back on her feet. ‘I could not believe it. The pump had given me back my life,’ she said. ‘Without this procedure, I would not have lived to see my youngest grandson who is now two and a half years old.’ Sherri is now back in South Carolina with her heart pump and her five grand-children, who prefer that she stay right where she is.”

Investment in Research Saves Lives and Money. http://www.researchamerica.org/advocacy/investment.html. Published 2005

Reference

Title
Investment in Research Saves Lives and Money
Publisher
Research!America
Publication Date
Published 2005
Authors
Research!America
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • The greater use of medications and revascularization would provide approximately a 17% reduction in 2 year mortality combined.  
  • Following the current path, heart disease cases will increase by 41.1% between 2003 and 2023. If an alternative path is taken, there will be 34.6% (9.4 million) fewer heart disease…  
  • Stroke rates among Afib patients
    In one year, 58,283 of the 1.265 million Medicare beneficiaries with atrial fibrillation that did not receive prophylaxis suffered a stroke. For those who did receive anti-coagulants, 38,468 suffered strokes.  
  • Effectiveness of pacemaker/defibrillators to control AFib
    Widespread use of pacemaker/defibrillators to control atrial fibrillation could result in a 50% decrease in stroke.  
  • Life expectancy and quality of life gains from AVR
    A study of 4,617 patients who underwent aortic valve replacement (AVR) over a period of 20 years found significant gains in life expectancy and quality of life — 43,166 net life-years…